{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:13:03Z","timestamp":1791162783911,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ejmech.2013.08.028","type":"journal-article","created":{"date-parts":[[2013,9,15]],"date-time":"2013-09-15T17:15:17Z","timestamp":1379265317000},"page":"527-536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["Design, synthesis and biological evaluation of 2-substituted quinolines as potential antileishmanial agents"],"prefix":"10.1016","volume":"69","author":[{"given":"Vadiraj S.","family":"Gopinath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakir","family":"Pinjari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra T.","family":"Dere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Vishwakarma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Shivahare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjunath","family":"Moger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palusa Sanath","family":"Kumar Goud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Ramanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prosenjit","family":"Bose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.V.S.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil K.","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Launay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2013.08.028_bib1","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1136\/bmj.1.2265.1249","article-title":"Note on the occurrence of Leishman-Donovan bodies in \u201ccachexial fevers\u201d including Kala-azar","volume":"1","author":"Rogers","year":"1904","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ejmech.2013.08.028_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0035-9203(01)90223-8","article-title":"The increase of risk factors for leishmaniasis worldwide","volume":"95","author":"Desjeux","year":"2001","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2013.08.028_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/clinids\/22.1.1","article-title":"Clinical spectrum of leishmaniasis","volume":"22","author":"Pearson","year":"1996","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2013.08.028_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1201-9712(99)90010-3","article-title":"Drug development output from 1975 to 1996 what proportion for tropical diseases?","volume":"3","author":"Trouiller","year":"1999","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2013.08.028_bib5","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1358\/dnp.2002.15.7.840077","article-title":"Visceral leishmaniasis: clinical features, pathology, diagnosis and chemotherapeutic developments","volume":"15","author":"Kumari","year":"2002","journal-title":"Drug News Prospect."},{"key":"10.1016\/j.ejmech.2013.08.028_bib6","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1001\/jama.298.16.1911","article-title":"Oral drug therapy for multiple neglected tropical diseases: a systematic review","volume":"298","author":"Reddy","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ejmech.2013.08.028_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0035-9203(99)90037-8","article-title":"Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions: a study of 938 cases","volume":"93","author":"Thakur","year":"1999","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2013.08.028_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00430-003-0201-2","article-title":"Miltefosine (Impavido): the first oral treatment against leishmaniasis","volume":"193","author":"Sindermann","year":"2004","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.ejmech.2013.08.028_bib9","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1365-3156.2009.02329.x","article-title":"Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases","volume":"14","author":"Patel","year":"2009","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.ejmech.2013.08.028_bib10","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1056\/NEJMoa066536","article-title":"Injectable paromomycin for visceral leishmaniasis in India","volume":"356","author":"Sundar","year":"2007","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2013.08.028_bib11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4269\/ajtmh.2001.65.685","article-title":"Phase 2 trial of WR6026, an orally administered 8-aminoquinoline, in the treatment of visceral leishmaniasis caused by Leishmania chagasi","volume":"65","author":"Dietze","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2013.08.028_bib12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4269\/ajtmh.1983.32.46","article-title":"Effectiveness of Allopurinol against Leishmania braziliensis panamensis in Aotus trivirgatus","volume":"32","author":"Walton","year":"1983","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2013.08.028_bib13","article-title":"Oral rifampicin in cases of cutaneous leishmaniasis with multiple lesions (a pilot study)","volume":"68","author":"Bumb","year":"2002","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"10.1016\/j.ejmech.2013.08.028_bib14","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1128\/AAC.40.3.586","article-title":"Activity of oral atovaquone alone and in combination with antimony in experimental visceral leishmaniasis","volume":"40","author":"Murray","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2013.08.028_bib15","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1128\/AAC.48.10.4067-4071.2004","article-title":"The antiparasitic compound licochalcone A is a potent echinocytogenic agent that modifies the erythrocyte membrane in the concentration range where antiplasmodial activity is observed","volume":"48","author":"Ziegler","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2013.08.028_bib16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0035-9203(93)90499-G","article-title":"Antileishmanial activity of the ether phospholipid ilmofosine","volume":"87","author":"Croft","year":"1993","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2013.08.028_bib17","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/infdis\/151.4.698","article-title":"Antileishmanial activity of human red blood cells containing Formycin A","volume":"151","author":"Berman","year":"1985","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2013.08.028_bib18","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0968-0896(00)00111-5","article-title":"Analysis of stereoelectronic properties of camptothecin analogues in relation to biological activity","volume":"8","author":"Werbovetz","year":"2000","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.08.028_bib19","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/AAC.37.4.859","article-title":"2-substituted quinoline alkaloids as potential antileishmanial drugs","volume":"37","author":"Fournet","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2013.08.028_bib20","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1016\/j.bmc.2003.09.007","article-title":"Synthesis and biological evaluation of substituted quinolines: potential treatment of protozoal and retroviral co-infections","volume":"11","author":"Fakhfakh","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2013.08.028_bib21","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1021\/ja01187a025","article-title":"Reactions of \u03b2-keto esters with aromatic amines. Syntheses of 2- and 4-hydroxyquinoline derivatives","volume":"70","author":"Hauser","year":"1948","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2013.08.028_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.actatropica.2004.11.009","article-title":"Efficacy of picroliv in combination with miltefosine, an orally effective antileishmanial drug against experimental visceral leishmaniasis","volume":"94","author":"Gupta","year":"2005","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejmech.2013.08.028_bib23","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1021\/jm400053v","article-title":"Discovery of a new class of natural product-inspired quinazolinone hybrid as potent antileishmanial agents","volume":"56","author":"Sharma","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2013.08.028_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.ejmech.2013.08.028_bib25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0001-706X(93)90083-N","article-title":"A\u00a0comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites","volume":"55","author":"Huber","year":"1993","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejmech.2013.08.028_bib26","series-title":"Experimental Chemotherapy","first-page":"257","article-title":"Chemotherapy of leishmaniasis","author":"Beveridge","year":"1963"},{"key":"10.1016\/j.ejmech.2013.08.028_bib27","first-page":"439","article-title":"Exploration of antileishmanial activity in heterocycles; results of their in\u00a0vivo & in\u00a0vitro bioevaluations","volume":"89","author":"Bhatnagar","year":"1989","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.ejmech.2013.08.028_bib28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0001-706X(02)00180-8","article-title":"Anilino-(2-bromophenyl) acetonitrile: a promising orally effective antileishmanial agent","volume":"84","author":"Gupta","year":"2002","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejmech.2013.08.028_bib29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/bmc.1373","article-title":"Systematic LC-MS\/MS bioanalytical method development that incorporates plasma phospholipids risk avoidance, usage of incurred sample and well thought-out chromatography","volume":"24","author":"Jemal","year":"2010","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ejmech.2013.08.028_bib30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jpba.2005.11.006","article-title":"A\u00a0new approach to evaluate regression models during validation of bioanalytical assays","volume":"41","author":"Singtoroj","year":"2006","journal-title":"J.\u00a0Pharm. Biomed. Anal"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523413005448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523413005448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:41:25Z","timestamp":1759326085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523413005448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":30,"alternative-id":["S0223523413005448"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2013.08.028","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of 2-substituted quinolines as potential antileishmanial agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2013.08.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}